• 1
    Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971; 285: 11821186.
  • 2
    Folkman J. Angiogenesis in cancer, vascular, rheumatoid arthritis and other disorders. Nat Med 1995; 1: 2731.
  • 3
    Carmeliet P,Jain RK. Angiogenesis in cancer and other diseases. Nat 2000; 407: 249257.
  • 4
    Papetti M,Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 2002; 285: 947970.
  • 5
    Gimbrone MA,Resnick N,Nagel T,Khachigian LM,Collins T,Topper JN, Hemodynamics, endothelial gene expression, and atherogenesis. Ann NY Acad Sci 1997; 811: 110.
  • 6
    Ross R. Mechanisms of disease: Atherosclerosis—An inflammatory disease. N Engl J Med 1999; 340: 115126.
  • 7
    Verma S,Buchanan MR,Anderso TJ. Endothelial function testing as a biomarker of vascular disease. Circulation 2003; 108: 20542059.
  • 8
    Davignon J,Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: 2732.
  • 9
    Koch AE,Harlow LA,Haines GK,Amento EP,Unemori EN,Wong WL,Pope RM,Ferrara N. Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994; 152: 41494156.
  • 10
    Clancy R,Marder G,Martin V,Belmont MH,Abramson SB,Buyon J. Circulating activated endothelial cells in systemic lupus erythematosus: Further evidence for diffuse vasculopathy. Arthritis Rheum 2001; 44: 12031208.
  • 11
    Meigs JB,Hu FB,Rifai N,Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004; 29: 19781986.
  • 12
    Drancourt M,George F,Brouqui P,Sampol J,Raoult D. Diagnosis of Mediterranean spotted fever by indirect immunofluorescence of Rickettsia conorii in circulating endothelial cells isolated with monoclonal antibody-coated immunomagnetic beads. J Infect Dis 1992; 166: 660663.
  • 13
    Percivalle E,Revello MG,Vago L,Morini F,Gerna G. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in HCMV infections with organ involvement. J Clin Invest 1993; 92: 663670.
  • 14
    Solovey A,Lin Y,Browne P,Choong S,Wayner E,Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 1997; 337: 15841590.
  • 15
    Chong AY,Blann AD,Patel J,Freestone B,Hughes E,Lip GYH. Endothelial dysfunction and damage in congestive heart failure: Relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation 2004; 110: 17941798.
  • 16
    Mutin M,Canavey I,Blann A,Bory M,Sampol J,Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999; 93: 29412948.
  • 17
    Muntunga M,Fulton B,Bullock R,Batchelor A,Gascoigne A,Gillespie JI,Baudouin SV. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 2001; 163: 195200.
  • 18
    Woywodt A,Schroeder M,Mengel M,Schwarz A,Gwinner W,Haller H,Haubitz M. Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage. Hypertension 2003; 41: 720723.
  • 19
    Kerbel RS,Kamen BA. The antiangiogenic basis of metronomic chemotherapy. Nat Rev 2004; 4: 423436.
  • 20
    Mancuso P,Burlini A,Pruneri G,Goldhirsch A,Martinelli G,Bertolini F. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001; 97: 36583661.
  • 21
    Beerepoot LV,Mehra N,Vermaat JSP,Zonnenberg BA,Gebbink MFGB,Voest EE. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 2004; 15: 139145.
  • 22
    Mancuso P,Rabascio C,Bertolini F. Strategies to investigate circulating endothelial cells in cancer. Pathophysiol Haemost Thromb 2004; 33: 503506.
  • 23
    Nakatani S,Takeshita S,Tsujimoto H,Kawamura Y,Sekine I. Circulating endothelial cells in Kawasaki disease. Clin Exp Immunol 2003; 131: 536540.
  • 24
    Segal MS,Bihorac A,Koc M Circulating endothelial cells: Tea leaves for renal disease. Am J Physiol Renal Physiol 2002; 283: F11F19.
  • 25
    Makin AJ,Chung NAY,Silverman SH,Blann AD,Lip GY. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Eur Heart J 2004; 25: 371376.
  • 26
    Quilici J,Banzet N,Paule P,Meynard JB,Mutin M,Bonnet JL,Ambrosi P,Sampol J,Dignat-George F. Circulating endothelial cell count as a diagnostic marker for non-ST-elevation acute coronary syndromes. Circulation 2004; 110: 15861591.
  • 27
    Blann A,Chong A,Freestone B,Lip G. Increased circulating endothelial cells as an index of endothelial damage in congestive heart failure. Br J Haematol 2004; 125 ( Suppl 1): 55.
  • 28
    Koc M,Richards HB,Bihorac A,Ross EA,Schold JD,Segal MS. Circulating endothelial cells are associated with future vascular events in hemodialysis patients. Kidney Int 2005; 67: 10781083.
  • 29
    Lefevre P,George F,Durand JM,Sampol J. Detection of circulating endothelial cells in thrombotic thrombocytopenic purpura. Thromb Haemost 1993; 69: 552.
  • 30
    Woywodt A,Streiber F,de Groot K,Regelsberger H,Haller H,Haubitz M. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 2003; 361: 206210.
  • 31
    Dignat-George F,Sampol J,Lip G,Blann A. Circulating endothelial cells: Realities and promises in vascular disorders. Pathophysiol Haemost Thromb 2004; 33: 495499.
  • 32
    Kagan M,Howard D,Bendele T,Rao C,Terstappen LWMM. Circulating tumor cells as cancer markers, a sample preparation and analysis system. In: DiamandisEP,FritscheHA,LiljaH,ChanDW,SchwartzM, editors. Tumor Markers: Physiology, Pathobiology, Technology and Clinical Applications. Washintgon, DC: AACC Press; 2002. pp 495498.
  • 33
    Kagan M,Howard D,Bendele T,Mayes J,Silvia J,Repollet M,Doyle J,Allard J,Tu N,Bui T,Russell T,Rao C,Hermann M,Rutner H,Terstappen LWMM. A sample preparation and analysis system for identification of circulating tumor cells. J Clin Ligand Assay 2002; 25: 104110.
  • 34
    Shih IM,Elder DE,Speicher D,Johnson JP,Herlyn M. Isolation and functional characterization of the A32 melanoma-associated antigen. Cancer Res 1994; 54: 25142520.
  • 35
    Bardin N,George F,Mutin M,Brisson C,Horschowski N,Francis V,Lesaule G,Sampol J. S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 1996; 48: 531539.
  • 36
    Pickl WF,Majdic O,Fischer GF,Petzelbauer P,Fai I,Waclavicek M,Stackl J,Scheinecker C,Vidicki T,Aschauer H,Johnson JP,Knapp W. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J Immunol 1997; 158: 21072115.
  • 37
    Gougos A,St-Jacques S,Greaves A,O'Connell PJ,d'Apice AJ,Behring HJ,Bernabeu C,van Mourik JA,Letarte M. Identification of distinct epitopes of endoglin, an RGD containing-glycoprotein of endothelial cells, leukemic cells and syncytiotrophoblasts. Int Immunol 1992; 4: 8392.
  • 38
    St-Jacques S,Cymerman U,Pece N,Letarte M. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-β binding protein of endothelial and stromal cells. Endocrinology 1994; 134: 26452657.
  • 39
    National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices: Approved guideline. Wayne, PA: NCCLS; 1999. NCCLS, 19: Document EP5-A.
  • 40
    Solberg HE. Approved recommendation (1987) on the theory of reference values, Part 5: Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem 1987; 25: 16451656.
  • 41
    Liberi PA,Rao CG,Terstappen LWMM. Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood. J Magn Magn Mater 2001; 225: 301307.
  • 42
    Combes V,Simon AC,Grau GE,Arnoux D,Camoin L,Sabatier F,Mutin M,Sanmarco M,Sampol J,Dignat-George F. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93102.
  • 43
    Smirnov DA,Foulk BW,Gerald V.Doyle GV,Connelly MC,Terstappen LWMM,O'Hara SM. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas. Cancer Res 2006; 66: 29182922.
  • 44
    Nanda A,St. Croix B. Tumor endothelial markers: New targets for cancer therapy. Curr Opin Oncol 2004; 16: 4449.
  • 45
    O'Brien KD,Allen MD,McDonald TO,Chait A,Harlan JM,Fishbein D,McCarty J,Ferguson M,Hudkins K,Benjamin CD. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993; 92: 945951.
  • 46
    Silver DA,Pellicer I,Fair WR,Heston WD,Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 1997; 3: 8185.
  • 47
    Mokrý J,Nìmeèek S. Angiogenesis of extra- and intraembryonic blood vessels is associated with expression of nestin in endothelial cells. Folia Biol (Praha) 1998; 44: 155161.
  • 48
    Tricot O,Mallat Z,Heymes C,Belmin J,Lesèche G,Tedgui A. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation 2000; 101: 24502453.